Contemporary Definitions and Classification of the Cardiomyopathies An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention, vol.113, pp.1807-1823, 2006. ,
The Diagnosis and Evaluation of Dilated Cardiomyopathy, J Am Coll Cardiol. 28 juin, vol.67, issue.25, pp.2996-3010, 2016. ,
Idiopathic Dilated Cardiomyopathy, N Engl J Med. 8 déc, vol.331, issue.23, pp.1564-75, 1994. ,
Epidemiology of dilated cardiomyopathy, Eur Heart J. 1 janv, vol.18, issue.1, pp.117-140, 1997. ,
Epidemiology of dilated cardiomyopathy: a still undetermined entity, Eur Heart J. 1 janv, vol.18, issue.1, pp.4-6, 1997. ,
Cardiomyopathies dilatées primitives et secondaires. EMC-Cardiol, janv, vol.6, issue.1, pp.1-12, 2011. ,
, Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies, Br Heart J. déc, vol.44, issue.6, pp.672-675, 1980.
, Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies, Circulation. 3 janv, vol.93, issue.5, pp.841-843, 1996.
The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy, Herz Kardiovaskuläre Erkrank, vol.32, issue.6, pp.446-451, 2007. ,
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases, Eur Heart J. 1 janv, vol.29, issue.2, pp.270-276, 2008. ,
Atlas of the clinical genetics of human dilated cardiomyopathy, Eur Heart J. 7 mai, vol.36, issue.18, pp.1123-1158, 2015. ,
Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals, Genet Med Off J Am Coll Med Genet, vol.12, issue.11, pp.655-67, 2010. ,
Truncations of Titin Causing Dilated Cardiomyopathy, N Engl J Med. 16 févr, vol.366, issue.7, pp.619-647, 2012. ,
Cardiac troponin T (TNNT2) mutations in chinese dilated cardiomyopathy patients, BioMed Res Int, p.907360, 2014. ,
Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects, Virchows Arch. 26 juill, vol.443, issue.5, pp.664-71, 2003. ,
A novel mutation in lamin a/c causing familial dilated cardiomyopathy associated with sudden cardiac death, J Card Fail. mars, vol.21, issue.3, pp.217-242, 2015. ,
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure, Science. 1 mai, vol.280, issue.5364, pp.750-752, 1998. ,
A novel dystrophin deletion mutation in a becker muscular dystrophy patient with early-onset dilated cardiomyopathy, Can J Cardiol. août, vol.30, issue.8, pp.956-957, 2014. ,
Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma, Hum Mol Genet. 11 janv, vol.9, issue.18, pp.2761-2767, 2000. ,
Dilated cardiomyopathy. The Lancet. 5 mars, vol.375, pp.752-62, 2010. ,
Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes, Am J Physiol-Heart Circ Physiol. 1 avr, vol.282, issue.4, pp.1216-1238, 2002. ,
Alcoholic cardiomyopathy*: Incidence, clinical characteristics, and pathophysiology, Chest. 1 mai, vol.121, issue.5, pp.1638-50, 2002. ,
Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy, Ann Intern Med, vol.137, issue.5_Part_1, pp.321-326, 2002. ,
Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study, Eur J Cancer. sept, vol.51, issue.13, pp.1660-1666, 2015. ,
Ageing is a risk factor in imatinib mesylate cardiotoxicity, Eur J Heart Fail. janv, vol.16, issue.4, pp.367-76, 2014. ,
, Insuffisance cardiaque chronique. Cardiomyopathies GIBELIN Pierre Collection "Les Précis"-Edition Lavoisier Médecine Science
Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis, Circulation, vol.114, issue.15, pp.1581-90, 2006. ,
Clinicopathologic description of myocarditis, J Am Coll Cardiol. déc, vol.18, issue.7, pp.1617-1643, 1991. ,
A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, N Engl J Med. 24 avr, vol.336, issue.17, pp.1202-1209, 1997. ,
Peripartum Cardiomyopathy: Recent Insights in its Pathophysiology, Trends Cardiovasc Med. juill, vol.18, issue.5, pp.173-182, 2008. ,
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies, N Engl J Med. 21 janv, vol.374, issue.3, pp.233-274, 2016. ,
Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial, Am Heart J. 1 avr, vol.157, issue.4, p.762, 2009. ,
Depressed Coronary Flow Reserve Is Associated With Decreased Myocardial Capillary Density in Patients With Heart Failure Due to Idiopathic Dilated Cardiomyopathy, J Am Coll Cardiol, vol.52, issue.17, pp.1391-1399, 2008. ,
Nonischemic Dilated Cardiomyopathy: Results of Noninvasive and Invasive Evaluation in 310 Patients and Clinical Significance of Bundle Branch Block, Pacing Clin Electrophysiol, vol.31, issue.11, pp.1383-90, 2008. ,
Diagnostic Accuracy of Multidetector Computed Tomography Coronary Angiography in Patients With Dilated Cardiomyopathy, J Am Coll Cardiol. 22 mai, vol.49, issue.20, pp.2044-50, 2007. ,
SixtyFour-Slice Multidetector Computed Tomography An Accurate Imaging Modality for the Evaluation of Coronary Arteries in Dilated Cardiomyopathy of Unknown Etiology, Circ Cardiovasc Imaging. 5 janv, vol.2, issue.3, pp.199-205, 2009. ,
Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: Differential diagnosis and prediction of cardiac outcome, Magn Reson Imaging. 1 févr, vol.32, issue.2, pp.118-142, 2014. ,
Prognostic impact of late gadolinium enhancement by cardiac magnetic resonance imaging in patients with nonischaemic dilated cardiomyopathy, Int J Cardiol, vol.168, issue.5, pp.4979-80, 2013. ,
Lamin A/C mutation: An easily missed opportunity, Int J Cardiol. 15 févr, vol.181, p.44, 2015. ,
Recovery of normal ventricular function in patients with dilated cardiomyopathy: Predictors of an increasingly prevalent clinical event, Am Heart J. janv, vol.155, issue.1, pp.69-74, 2008. ,
Survival after the onset of congestive heart failure in Framingham Heart Study subjects, Circulation. 1 juill, vol.88, issue.1, pp.107-122, 1993. ,
Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction: A Pooled Analysis of 5 Randomized Control Trials, J Am Coll Cardiol. 3 avr, vol.49, issue.13, pp.1450-1458, 2007. ,
Differences between African Americans and whites in the outcome of heart failure: Evidence for a greater functional decline in African Americans, Am Heart J. juin, vol.143, issue.6, pp.1058-67, 2002. ,
Natural history and therapy of AL cardiac amyloidosis, Heart Fail Rev. 2 déc, vol.20, issue.2, pp.155-62, 2014. ,
The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction, J Am Coll Cardiol. 1 mars, vol.35, issue.3, pp.681-690, 2000. ,
The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure, J Am Coll Cardiol, vol.40, issue.6, pp.1106-1119, 2002. ,
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction, J Am Coll Cardiol. août, vol.38, issue.2, pp.421-429, 2001. ,
Association of Depression and Survival in Patients with Chronic Heart Failure over 12 Years, Psychosomatics, vol.53, issue.4, pp.339-385, 2012. ,
One-year mortality among unselected outpatients with heart failure, Eur Heart J. 1 déc, vol.23, issue.23, pp.1861-1867, 2002. ,
Clinical Determinants of Mortality in Patients With Angiographically Diagnosed Ischemic or Nonischemic Cardiomyopathy, J Am Coll Cardiol, vol.30, issue.4, pp.1002-1010, 1997. ,
The relationship between obesity and mortality in patients with heart failure, J Am Coll Cardiol. sept, vol.38, issue.3, pp.789-95, 2001. ,
Obesity and the Obesity Paradox in Heart Failure, Can J Cardiol. févr, vol.31, issue.2, pp.195-202, 2015. ,
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. 17 sept, vol.376, pp.875-85, 2010. ,
Heart Rate Variability in Risk Stratification of Cardiac Patients, Prog Cardiovasc Dis. sept, vol.56, issue.2, pp.153-162, 2013. ,
Nonsustained Ventricular Tachycardia in Severe Heart Failure, Circulation. 15 déc, vol.94, issue.12, pp.3198-203, 1996. ,
The Impact of Anemia on the Prognosis of Chronic Heart Failure: A Meta-Analysis and Systemic Review, Congest Heart Fail. 1 mai, vol.15, issue.3, pp.123-153, 2009. ,
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure, J Am Coll Cardiol. 7 juill, vol.44, issue.1, pp.63-70, 2004. ,
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited, Am Heart J. janv, vol.139, issue.1, pp.78-84, 2000. ,
Salt and fluid restriction is effective in patients with chronic heart failure, Eur J Heart Fail, vol.15, issue.11, pp.1304-1314, 2013. ,
Aggressive fluid and sodium restriction in acute decompensated heart failure: A randomized clinical trial, JAMA Intern Med. 24 juin, vol.173, issue.12, pp.1058-64, 2013. ,
Effects of Enalapril on Mortality in Severe Congestive Heart Failure, N Engl J Med. 4 juin, vol.316, issue.23, pp.1429-1464, 1987. ,
Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure, N Engl J Med. 1 août, vol.325, issue.5, pp.293-302, 1991. ,
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials, Eur Heart J, vol.27, issue.22, pp.2682-2690, 2006. ,
CardiacResynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure, N Engl J Med. 20 mai, vol.350, issue.21, pp.2140-50, 2004. ,
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure, N Engl J Med. 14 avr, vol.352, issue.15, pp.1539-1588, 2005. ,
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms, J Am Coll Cardiol. 2 déc, vol.52, issue.23, pp.1834-1877, 2008. ,
CardiacResynchronization Therapy for Mild-to-Moderate Heart Failure, N Engl J Med. 16 déc, vol.363, issue.25, pp.2385-95, 2010. ,
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J. 14 juill, vol.37, issue.27, pp.2129-200, 2016. ,
FourYear Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression: The Importance of Performing Atrioventricular Junction Ablation in Patients With Atrial Fibrillation, J Am Coll Cardiol. 15 août, vol.48, issue.4, pp.734-777, 2006. ,
Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation, Eur Heart J. juill, vol.29, issue.13, pp.1644-52, 2008. ,
Biventricular Versus Right Ventricular Pacing in Patients with AV Block (BLOCK HF): Clinical Study Design and Rationale, J Cardiovasc Electrophysiol. 1 sept, vol.18, issue.9, pp.965-71, 2007. ,
Insights From a Cardiac Resynchronization Optimization Clinic as Part of a Heart Failure Disease Management Program, J Am Coll Cardiol. 3 mars, vol.53, issue.9, pp.765-73, 2009. ,
ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Eur Heart J, vol.36, issue.41, pp.2793-867, 2015. ,
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT), Circulation. 26 mars, vol.105, issue.12, pp.1453-1461, 2002. ,
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy, N Engl J Med. 20 mai, vol.350, issue.21, pp.2151-2159, 2004. ,
Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure, N Engl J Med. 20 janv, vol.352, issue.3, pp.225-262, 2005. ,
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008, Eur Heart J, vol.29, pp.2388-442, 2008. ,
Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy, J Thorac Cardiovasc Surg. 1 févr, vol.115, issue.2, pp.381-389, 1998. ,
New techniques for percutaneous repair of the mitral valve, Heart Fail Rev, vol.11, issue.3, pp.259-68 ,
, Agence de la biomédecine, 2015.
Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope, Open Cardiovasc Med J. 26 mai, vol.4, pp.127-161, 2010. ,
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by nonlinear analysis: oxygen uptake efficiency slope, Eur Heart J. 1 mars, vol.27, issue.6, pp.684-90, 2006. ,
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J. 14 juill, vol.37, issue.27, pp.2129-200, 2016. ,
, , 2012.
Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, vol.60, issue.14, pp.1297-313, 2008. ,
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008, Eur Heart J, vol.29, pp.2388-442, 2008. ,
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials, Eur Heart J, vol.27, issue.22, pp.2682-2690, 2006. ,
Competing risk analysis of cause-specific mortality in patients with an implantable cardioverterdefibrillator: The EVADEF cohort study, Am Heart J. févr, vol.157, issue.2, pp.391-397, 2009. ,
Survival of Patients Receiving a Primary Prevention Implantable CardioverterDefibrillator in Clinical Practice vs Clinical Trials, JAMA J Am Med Assoc. 2 janv, vol.309, issue.1, pp.55-62, 2013. ,
Survival After Shock Therapy in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy-Defibrillator Recipients According to Rhythm Shocked: The ALTITUDE Survival by Rhythm Study, J Am Coll Cardiol, vol.62, issue.18, pp.1674-1683, 2013. ,
Survival After Primary Prevention Implantable Cardioverter-Defibrillator Placement Among Patients With Chronic Kidney Disease, Circ Arrhythm Electrophysiol. 10 janv, vol.7, issue.5, pp.793-802, 2014. ,
Effect of Age on Survival and Causes of Death After Primary Prevention Implantable CardioverterDefibrillator Implantation, Am J Cardiol. 15 mai, vol.115, issue.10, pp.1415-1437, 2015. ,
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators, Circ Heart Fail. 9 janv, vol.8, issue.5, pp.927-964, 2015. ,
Prognostic importance of defibrillator shocks in patients with heart failure, N Engl J Med, vol.359, issue.10, pp.1009-1026, 2008. ,
A Systematic Review and Meta-analysis of the Association Between Implantable CardioverterDefibrillator Shocks and Long-term Mortality, Can J Cardiol. 1 mars, vol.31, issue.3, pp.270-277, 2015. ,
Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register, Europace. 1 août, vol.15, issue.8, pp.1150-1157, 2013. ,
Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial, J Cardiovasc Electrophysiol. 1 juill, vol.25, issue.7, pp.763-70, 2014. ,
Predictors and Clinical Impact of Inappropriate Implantable Cardioverter-Defibrillator Shocks in Korean Patients, J Korean Med Sci. juin, vol.27, issue.6, pp.619-643, 2012. ,
Reduction in Inappropriate Therapy and Mortality through ICD Programming, N Engl J Med. 13 déc, vol.367, issue.24, pp.2275-83, 2012. ,
Contributions of remote monitoring to the follow-up of implantable cardioverterdefibrillator leads under advisory, Eur Heart J. sept, vol.31, issue.18, pp.2246-52, 2010. ,
Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study, Europace. 1 août, vol.17, issue.8, pp.1267-75, 2015. ,
Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trialtesting execution of the recommendations, Eur Heart J. 21 mai, vol.35, issue.20, pp.1345-52, 2014. ,
Outcomes With Left Bundle Branch Block and Mildly to Moderately Reduced Left Ventricular Function.pdf, JACC Heart Fail, 2016. ,
Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION), Trial. Circulation. 19 déc, vol.114, issue.25, pp.2766-72, 2006. ,
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II), Trial. Circulation. 6 juill, vol.111, issue.22, pp.2898-905, 2005. ,
Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction, Europace. 1 juill, vol.14, issue.7, pp.968-74, 2012. ,
The benefit of implantable cardioverter defibrillator programming in MADIT-RIT: more for less?, Europace. 1 sept, vol.15, issue.9, pp.1229-1259, 2013. ,
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure, N Engl J Med ,
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT), Circulation. 26 mars, vol.105, issue.12, pp.1453-1461, 2002. ,
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia-AMIOVIRT, J Am Coll Cardiol. 21 mai, vol.41, issue.10, pp.1707-1719, 2003. ,
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy, N Engl J Med. 20 mai, vol.350, issue.21, pp.2151-2159, 2004. ,
Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure, N Engl J Med. 20 janv, vol.352, issue.3, pp.225-262, 2005. ,
CardiacResynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure, N Engl J Med. 20 mai, vol.350, issue.21, pp.2140-50, 2004. ,
ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Eur Heart J, vol.36, issue.41, pp.2793-867, 2015. ,
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials, JAMA. 15 déc, vol.292, issue.23, pp.2874-2883, 2004. ,
Lower Mortality Associated With Overweight in the U.S. National Health Interview Survey, Medicine, vol.15, issue.2016 ,
Being Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations Audit, Crit Care Med. déc, vol.43, issue.12, pp.2623-2655, 2015. ,
Overweight, but not obesity, paradox on mortality following coronary artery bypass grafting, J Cardiol. 1 sept, vol.68, issue.3, pp.215-236, 2016. ,
Obesity and the Obesity Paradox in Heart Failure, Can J Cardiol. févr, vol.31, issue.2, pp.195-202, 2015. ,
Obesity as a prognostic factor in chronic symptomatic heart failure, Am Heart J. 1 déc, vol.150, issue.6, pp.1233-1242, 2005. ,
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial, Eur J Heart Fail. 1 avr, vol.9, issue.4, pp.397-402, 2007. ,
The relationship between obesity and mortality in patients with heart failure, J Am Coll Cardiol. sept, vol.38, issue.3, pp.789-95, 2001. ,
The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction, J Am Coll Cardiol. 1 mars, vol.35, issue.3, pp.681-690, 2000. ,
The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure, J Am Coll Cardiol, vol.40, issue.6, pp.1106-1119, 2002. ,
Predictors of Mortality in Patients With an Implantable Cardiac Defibrillator: A Systematic Review and Metaanalysis, Can J Cardiol. 1 déc, vol.29, issue.12, pp.1729-1769, 2013. ,
Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator, Circulation. 21 déc, vol.110, issue.25, pp.3760-3765, 2004. ,
Shocks as predictors of survival in patients with implantable cardioverter-defibrillators, J Am Coll Cardiol. juill, vol.34, issue.1, pp.204-214, 1999. ,
Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients, Europace. 1 août, vol.8, issue.8, pp.566-72, 2006. ,
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable CardioverterDefibrillators for Primary Prevention of Sudden Cardiac Death, J Am Coll Cardiol. 15 févr, vol.57, issue.7, pp.821-829, 2011. ,
,
Reduction in Inappropriate Therapy and Mortality through ICD Programming, N Engl J Med. 13 déc, vol.367, issue.24, pp.2275-83, 2012. ,
Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction, Europace. 1 juill, vol.14, issue.7, pp.968-74, 2012. ,
An Entirely Subcutaneous Implantable Cardioverter-Defibrillator, N Engl J Med. 1 juill, vol.363, issue.1, pp.36-44, 2010. ,
The Subcutaneous Defibrillator: A Review of the Literature, J Am Coll Cardiol. 22 avr, vol.63, issue.15, pp.1473-1482, 2014. ,
ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Eur Heart J, vol.36, issue.41, pp.2793-867, 2015. ,
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure, N Engl J Med ,